Quality assurance of the EORTC Trial 22881/10882: boost versus no boost in breast conserving therapy. An overview (Q40899655)

24 September 2017

Quality assurance of the EORTC Trial 22881/10882: boost versus no boost in breast conserving therapy. An overview (English)

1 reference

24 September 2017

G van Tienhoven

1

1 reference

24 September 2017

B J Mijnheer

series ordinal

2

1 reference

24 September 2017

H Bartelink

series ordinal

3

1 reference

24 September 2017

D G González

series ordinal

4

1 reference

24 September 2017

1 April 1997

1 reference

Strahlentherapie und Onkologie

24 September 2017

1 reference

24 September 2017

173

1 reference

24 September 2017

4

1 reference

24 September 2017

201-207

1 reference

https://scigraph.springernature.com/pub.10.1007/bf03039289

24 September 2017

0 references

cites work

Quality assurance control in the EORTC cooperative group of radiotherapy. 1. Assessment of radiotherapy staff and equipment. European Organization for Research and Treatment of Cancer.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF03039289

In vivo dosimetry with TLD in conservative treatment of breast cancer patients treated with the EORTC protocol 22881

21 January 2018

1 reference

12 December 2020

Should inhomogeneity corrections be applied during treatment planning of tangential breast irradiation?

1 reference

12 December 2020

Quality assurance of the EORTC radiotherapy trial 22863 for prostatic cancer: the dummy run

1 reference

12 December 2020

The simultaneous boost technique: the concept of relative normalized total dose

1 reference

12 December 2020

Breast irradiation in the lateral decubitus position: technique of the Institut Curie

1 reference

12 December 2020

EORTC guidelines for writing protocols for clinical trials of radiotherapy

1 reference

12 December 2020

Quality assurance control in the EORTC cooperative group of radiotherapy. 2. Dosimetric intercomparison

1 reference

12 December 2020

Quality control of validity of data collected in clinical trials. EORTC Study Group on Data Management (SGDM).

1 reference

12 December 2020

Three-dimensional dose distribution of tangential breast treatment: a national dosimetry intercomparison

1 reference

12 December 2020

Impact of irradiation technique and tumor extent in tumor control and survival of patients with unresectable non-oat cell carcinoma of the lung. Report by the radiation therapy oncology group

1 reference

12 December 2020

The need for immediate monitoring of treatment parameters and uniform assessment of patient data in clinical trials. A quality control study of the EORTC Radiotherapy and Lung Cancer Cooperative Groups.

1 reference

12 December 2020

Quality control review for radiotherapy of small breast cancer: analysis of 708 patients in the GBSG I trial. German Breast Study Group (GBSG).

1 reference

12 December 2020

In vivo dosimetry during tangential breast treatment

1 reference

12 December 2020

Mailed TL dosimetry programme for machine output check and clinical application in the EORTC radiotherapy group

1 reference

12 December 2020

Quality assurance control in the EORTC cooperative group of radiotherapy. 3. Intercomparison in an anatomical phantom

1 reference

12 December 2020

Entrance and exit TL-dosimetry in the conservative treatment of breast cancer: a pilot study for the EORTC-Radiotherapy Cooperative Group

1 reference

12 December 2020

Alpha/beta value and the importance of size of dose per fraction for late complications in the supraglottic larynx

1 reference

12 December 2020

Quality assurance of the EORTC trial 22881/10882: "assessment of the role of the booster dose in breast conserving therapy": the Dummy Run. EORTC Radiotherapy Cooperative Group

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03039289

1 reference

24 September 2017

1 reference